Showing results (541-550 of 689) with videos related to
Sort By:
Pageof 69
Journal of the American College of Cardiology|August 9, 2014
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.Plos One|July 10, 2026
Tear-film imaging measurements of the lipid and muco-aqueous layers and their association with dry eye disease signs and symptoms in adults: A pilot, prospective, cross-sectional study at a tertiary eye care centerIsaac M Tessone, Richard B Rosen, Hernan Rios, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Reduction of paclitaxel-induced peripheral neuropathy with glutamineL Vahdat, K Papadopoulos, D Lange, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapyJ A de Lemos, E M Antman, D A Morrow, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 15, 2021
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trialSarah E Nelson, Robert P Giugliano, Elliott M Antman, et al.American Heart Journal|August 9, 2005
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialE Magnus Ohman, Frans Van de Werf, Elliott M Antman, et al.Journal of the American College of Cardiology|June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trialC Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.Thrombosis and Haemostasis|June 30, 2011
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44Andrew L Frelinger, Alan D Michelson, Stephen D Wiviott, et al.Circulation|April 12, 2021
Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy StatementKeith Churchwell, Elliott Antman, Jill Birnbaum, et al.American Heart Journal|June 30, 2001
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudyV S Srinivas, C P Cannon, C M Gibson, et al.Pageof 69